Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states
about
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.Chromatin Remodeling BAF (SWI/SNF) Complexes in Neural Development and Disorders.SWI/SNF complex in cancerRapid and reversible epigenome editing by endogenous chromatin regulatorsSmarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin.Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.Chemically Controlled Epigenome Editing through an Inducible dCas9 System.A General Non-Radioactive ATPase Assay for Chromatin Remodeling Complexes.Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis.A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.Epigenetic Alterations in Bone and Soft Tissue Tumors.Epigenetic regulation in medulloblastoma.MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts.Rapid chromatin repression by Aire provides precise control of immune tolerance.Chromatin dependencies in cancer and inflammation.CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.Chromatin reprogramming in breast cancer.ATP-Dependent Chromatin Remodeling During Cortical Neurogenesis.Composition and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Disease.Polycomb repressive complex 1 shapes the nucleosome landscape but not accessibility at target genesMutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability Disorders
P2860
Q38706007-F6403337-4186-499D-B341-31D67C2D7A1DQ39229171-88CD0279-9B33-423E-8A8E-8F7338B154F6Q41220897-595FC82C-3BE4-4AB9-9138-F233C419D8AFQ41686751-407ED0CD-9CC6-4CF4-8554-3B0936625A09Q41701373-D13E270D-9C70-4A55-9043-9890EBCE2F75Q42222276-A5DAD78F-0E9C-49F7-8FCF-8948F1B60B09Q42291151-6781C70C-D7EF-4818-A5C0-6D11FB6D918DQ42378723-8F103F1F-DAAD-4316-B394-64EC5DA1B7C8Q45768274-C53A50DE-AE15-4035-8DCE-3D318FDB74C7Q46196399-302D63B7-ADAF-4336-8DB6-AD07BD5CC0ACQ47117026-1C9227D8-B026-4D77-9513-CDB2EEC49274Q47557998-311D892E-A670-4D94-BF10-6704ED4FB6B3Q47748373-6B8522B9-1A13-468A-AF6E-74CF1A5D6C6DQ47835503-9EA6045C-E1C1-4176-9CFF-3391074A1BFDQ47900778-379B0798-8C6D-40B9-A4D6-48B4BA46412BQ48121595-62004E2C-56A9-45DB-B1DB-E5DF8A6F4080Q48239289-3C38935E-68BB-48A3-AC35-1DD2F92E11C4Q49565575-964CB3AD-64A6-497F-9C70-5CE51CF160EEQ50055585-398ADBAF-98CA-42E8-8BA1-A116B27C4C31Q50420957-7672A31A-5763-4FE8-9AB0-49C0199720D0Q52310380-59B8C446-3BC1-4AB1-A40A-13D11B9C31A2Q52311702-0071FED9-D612-4D9C-8A14-7BAF65F9CD1DQ52681632-8ED6D448-BDA8-4882-A0E4-2FE81EB10FC1Q58792894-53E6557F-AA40-43CF-AF4A-11A5A36F4B63Q58801736-634AC445-2FED-4A7D-90E1-E75944F9810F
P2860
Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dynamics of BAF-Polycomb compl ...... in normal and oncogenic states
@en
type
label
Dynamics of BAF-Polycomb compl ...... in normal and oncogenic states
@en
prefLabel
Dynamics of BAF-Polycomb compl ...... in normal and oncogenic states
@en
P2093
P2860
P50
P356
P1433
P1476
Dynamics of BAF-Polycomb compl ...... in normal and oncogenic states
@en
P2093
Christopher M Weber
Erik L Miller
Gerald R Crabtree
Joseph P Calarco
P2860
P2888
P304
P356
10.1038/NG.3734
P407
P577
2016-12-12T00:00:00Z
P6179
1048610845